Article
Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia
22 Jul 2024
Abstract excerpt
Approximately 25–35% of adult patients with acute myeloid leukemia (AML) carries NPM1 mutation, which generally indicated a favorable outcome in the absence of FLT3-ITD mutation [ 1 ]. NPM1 mutations are absent in clonal hematopoiesis, and have been considered as AML initiating lesions [ 2 ]. Research on co-mutation characteristics of NPM1 -mutated patients concentrated on FLT3-ITD , which has been suggested to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
